Trading Signals: IOVA Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Iovance Biotherapeutics Inc)
| IOVA latest price $23.4900 (4.21%) ($22.6800 - $23.9000) on Tue. Feb. 4, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.67% (three month average) | RSI | 42 | Latest Price | $23.4900(4.21%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | IOVA advances 1.3% a day on average for past five trading days. | Weekly Trend | IOVA declines -2.6% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support IOVA advance at 0% a week (0% probability) IBB(49%) ARKG(48%) XBI(48%) IWO(44%) ARKK(43%) | Factors Impacting IOVA price | IOVA will decline at least -1.835% in a week (0% probabilities). VIXM(-29%) VXX(-16%) UUP(-10%) TLT(-2%) TBT(-1%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.835% (StdDev 3.67%) | Hourly BBV | 0 () | Intraday Trend | 1.9% | | | |
|
Resistance Level | $23.7 | 5 Day Moving Average | $22.56(4.12%) | 10 Day Moving Average | $22.46(4.59%) | 20 Day Moving Average | $23.7(-0.89%) | To recent high | -20.1% | To recent low | 14.8% | Market Cap | $3.44b | | | | Iovance Biotherapeutics, Inc. operates as a biotechnology company. The firm engages in the development and commercialization of novel cancer immunotherapy products. Its lead product candidate, LN-144 for metastatic melanoma, is an autologous adoptive cell therapy utilizing tumor-infiltrating lymphocytes, or TIL, which are T cells derived from patients' tumors. The company was founded by Robert T. Brooke on September 17, 2007 and is headquartered in San Carlos, CA. |